RESUMEN
23Na-MRI provides information on Na+ content, and its application in the medical field has been highly anticipated. However, for existing clinical 1H-MRI systems, its implementation requires an additional broadband RF transmitter, dedicated transceivers, and RF coils for Na+ imaging. However, a standard medical MRI system cannot often be modified to perform 23Na imaging. We have developed an add-on crossband RF repeater system that enables 23Na-MRI simply by inserting it into the magnet bore of an existing 1H MRI. The three axis gradient fields controlled by the 1H-MRI system were directly used for 23Na imaging without any deformation. A crossband repeater is a common technique used for amateur radio. This concept was proven by a saline solution phantom and in vivo mouse experiments. This add-on RF platform is applicable to medical 1H MRI systems and can enhance the application of 23Na-MRI in clinical usage.
Asunto(s)
Imagen por Resonancia Magnética , Ondas de Radio , Ratones , Animales , Imagen por Resonancia Magnética/métodos , Fantasmas de Imagen , ImanesRESUMEN
To identify the decoherence origin, frequency spectra using multiple π-pulses have been extensively studied. However, little has been discussed on how to define the spectral intensities from multiple-echo decays and how to incorporate the Hahn-echo T2 in the noise spectra. Here, we show that experiments based on two theories solve these issues. As proved in the previous theory, the spectral intensity is given as the decay in the long-time limit. Unlike the initial process of decays, this definition is not only theoretically proven but also validated experimentally, since long-time behaviors are generally free from experimental artifacts. The other is the fluctuation-dissipation theory, with which the Hahn-echo T2 is utilized as the zero-frequency limit of the noise spectrum and as an answer to the divergent issue on the 1/fn noises. As a result, arsenic nuclear spins are found to exhibit 1/f2 dependences over two orders of magnitude in all the substrates of un-doped, Cr-doped semi-insulating and Si-doped metallic GaAs at 297 K. The 1/f2 dependence indicates that the noise is dominated by a single source with characteristic frequency fcun = 170 ± 10 Hz, fcCr = 210 ± 10 Hz and fcSi = 460 ± 30 Hz. These fc values are explained by a model that the decoherence is caused by the fluctuations of next-nearest-neighboring nuclear spins.
Asunto(s)
Artritis Infecciosa/complicaciones , Bacteriemia/complicaciones , Fascitis Necrotizante/microbiología , Infecciones Estreptocócicas/complicaciones , Streptococcus agalactiae/aislamiento & purificación , Colgajos Quirúrgicos/irrigación sanguínea , Antibacterianos/uso terapéutico , Artritis Infecciosa/microbiología , Artritis Infecciosa/terapia , Bacteriemia/diagnóstico , Bacteriemia/tratamiento farmacológico , Terapia Combinada , Desbridamiento/métodos , Progresión de la Enfermedad , Quimioterapia Combinada , Fascitis Necrotizante/fisiopatología , Fascitis Necrotizante/terapia , Estudios de Seguimiento , Humanos , Extremidad Inferior , Masculino , Persona de Mediana Edad , Medición de Riesgo , Índice de Severidad de la Enfermedad , Infecciones Estreptocócicas/diagnóstico , Infecciones Estreptocócicas/tratamiento farmacológico , Colgajos Quirúrgicos/trasplante , Resultado del Tratamiento , Extremidad Superior , Cicatrización de Heridas/fisiologíaRESUMEN
It is said that the microgravity environment positively affects the quality of protein crystal growth. The formation of a protein depletion zone and an impurity depletion zone due to the suppression of convection flow were thought to be the major reasons. In microgravity, the incorporation of molecules into a crystal largely depends on diffusive transport, so the incorporated molecules will be allocated in an orderly manner and the impurity uptake will be suppressed, resulting in highly ordered crystals. Previously, these effects were numerically studied in a steady state using a simplified model and it was determined that the combination of the diffusion coefficient of the protein molecule (D) and the kinetic constant for the protein molecule (ß) could be used as an index of the extent of these depletion zones. In this report, numerical analysis of these depletion zones around a growing crystal in a non-steady (i.e. transient) state is introduced, suggesting that this model may be used for the quantitative analysis of these depletion zones in the microgravity environment.
Asunto(s)
Cristalización , Muramidasa/química , Modelos Teóricos , IngravidezRESUMEN
A method is proposed for obtaining the spectrum for noise that causes the phase decoherence of a qubit directly from experimentally available data. The method is based on a simple relationship between the spectrum and the coherence time of the qubit in the presence of a π pulse sequence. The relationship is found to hold for every system of a qubit interacting with the classical-noise, bosonic, and spin baths.
RESUMEN
Recently, the authors experienced four patients who had refractory hypertension and neurovascular compression of the rostral ventrolateral medulla (RVLM). One of them, a 49-year-old woman, had undergone continuous intravenous drip injections of calcium channel blockers and ß-blockers for more than 3 years because of severe and refractory hypertension. The patients had undergone microvascular decompression (MVD) of the RVLM, and the changes in blood pressure (BP) and sympathetic nerve activities were recorded. In these patients, BP decreased to the normal range without any antihypertensive drugs 2 to 3 months after MVD. The tibial sympathetic nerve activities under resting and stress conditions significantly decreased, and plasma levels of norepinephrine, urinary levels of adrenaline, and plasma renin activity were also significantly decreased after MVD of RVLM. In some patients with refractory hypertension, arterial compression of the RVLM enhances sympathetic nerve activity and renin-angiotensin system to thereby increase BP. In these patients, the operative decompression of the RVLM could lower BP via restoration of sympathetic nerve activities and the renin-angiotensin system.
Asunto(s)
Presión Sanguínea/fisiología , Hipertensión/fisiopatología , Hipertensión/cirugía , Bulbo Raquídeo/cirugía , Cirugía para Descompresión Microvascular , Sistema Nervioso Simpático/fisiología , Adulto , Antihipertensivos/uso terapéutico , Epinefrina/orina , Femenino , Humanos , Hipertensión/tratamiento farmacológico , Imagen por Resonancia Magnética , Masculino , Bulbo Raquídeo/patología , Persona de Mediana Edad , Norepinefrina/sangre , Renina/sangre , Sistema Renina-Angiotensina/fisiología , Insuficiencia del Tratamiento , Resultado del TratamientoRESUMEN
Klotho is a circulating protein, and Klotho deficiency disturbs endothelial integrity, but the molecular mechanism is not fully clarified. We report that vascular endothelium in Klotho-deficient mice showed hyperpermeability with increased apoptosis and down-regulation of vascular endothelial (VE)-cadherin because of an increase in VEGF-mediated internal calcium concentration ([Ca(2+)]i) influx and hyperactivation of Ca(2+)-dependent proteases. Immunohistochemical analysis, the pull-down assay using Klotho-fixed agarose, and FRET confocal imaging confirmed that Klotho protein binds directly to VEGF receptor 2 (VEGFR-2) and endothelial, transient-receptor potential canonical Ca(2+) channel 1 (TRPC-1) and strengthens the association to promote their cointernalization. An in vitro mutagenesis study revealed that the second hydrolase domain of Klotho interacts with sixth and seventh Ig domains of VEGFR-2 and the third extracellular loop of TRPC-1. In Klotho-deficient endothelial cells, VEGF-mediated internalization of the VEGFR-2/TRPC-1 complex was impaired, and surface TRPC-1 expression increased 2.2-fold; these effects were reversed by supplementation of Klotho protein. VEGF-mediated elevation of [Ca(2+)]i was sustained at higher levels in an extracellular Ca(2+)-dependent manner, and normalization of TRCP-1 expression restored the abnormal [Ca(2+)]i handling. These findings provide evidence that Klotho protein is associated with VEGFR-2/TRPC-1 in causing cointernalization, thus regulating TRPC-1-mediated Ca(2+) entry to maintain endothelial integrity.
Asunto(s)
Glucuronidasa/metabolismo , Canales Catiónicos TRPC/metabolismo , Receptor 2 de Factores de Crecimiento Endotelial Vascular/metabolismo , Animales , Sitios de Unión , Calcio/metabolismo , Canales de Calcio , Glucuronidasa/deficiencia , Proteínas Klotho , Ratones , Unión ProteicaRESUMEN
BACKGROUND: The klotho gene and its protein product are mainly expressed in the kidney. The klotho protein induces suppression of multiple aging-related phenotypes, and homozygous klotho gene mutant mice display various senescent morbidity. Chronic inhibition of nitric oxide synthase (NOS) induces arteriosclerosis, while HMG-CoA reductase inhibitors (statins) have pleiotropic vascular protective effects besides cholesterol lowering. Therefore, the present studies were performed to determine whether chronic NOS blockade would affect anti-ageing klotho protein expression. In addition, the effects of statins on klotho protein expression and arteriosclerosis in these rats were investigated. METHODS: Forty-two rats were divided into 6 groups as follows: (1) control, (2) NOS blockade, (3) atorvastatin (10 mg/kg/day), (4) pitavastatin (3 mg/kg/day), (5) NOS blockade+atorvastatin, (6) NOS blockade+pitavastatin. To induce arteriosclerosis further, a cuff was placed around the left femoral artery in each rat. After 4 weeks observation, rats were killed and renal klotho expression and the level of arteriosclerosis were examined. RESULTS: The rats of chronic NOS inhibition developed hypertension, while statin treatment did not affect blood pressure in the rats with or without NOS blockade. Despite statin treatment, plasma levels of lipids did not differ among 6 groups. Immunohistochemical staining revealed that klotho protein was localized in the renal tubules. Chronic NOS inhibition markedly reduced renal klotho protein expression, while treatment with atorvastatin or pitavastatin completely prevented the reduction of klotho expression induced by NOS inhibition. In addition, statin treatment significantly improved arteriosclerotic lesions induced by NOS inhibition and cuff placement. CONCLUSION: Since statin treatment did not alter blood pressure or serum lipid profiles, a novel vascular protective effect of statins via enhancing anti-aging klotho protein expression is suggested.
Asunto(s)
Anticolesterolemiantes/uso terapéutico , Arteriosclerosis/prevención & control , Glucuronidasa/biosíntesis , Ácidos Heptanoicos/uso terapéutico , Inhibidores de Hidroximetilglutaril-CoA Reductasas/uso terapéutico , Óxido Nítrico Sintasa/antagonistas & inhibidores , Óxido Nítrico Sintasa/biosíntesis , Pirroles/uso terapéutico , Quinolinas/uso terapéutico , Animales , Atorvastatina , Proteínas Klotho , Masculino , Ratas , Ratas WistarRESUMEN
BACKGROUND: It is unclear whether a marked reduction of low-density lipoprotein-cholesterol (LDL-C) in patients with coronary heart disease (CHD) and mild hypercholesterolemia leads to less progression of atherosclerosis. METHODS AND RESULTS: Patients with CHD and hypercholesterolemia (100Asunto(s)
Anticolesterolemiantes/uso terapéutico
, Enfermedad Coronaria/diagnóstico por imagen
, Enfermedad Coronaria/tratamiento farmacológico
, Ácidos Heptanoicos/uso terapéutico
, Pirroles/uso terapéutico
, Anciano
, Atorvastatina
, LDL-Colesterol/sangre
, Angiografía Coronaria
, Enfermedad de la Arteria Coronaria/etiología
, Enfermedad Coronaria/sangre
, Vasos Coronarios/diagnóstico por imagen
, Vasos Coronarios/patología
, Progresión de la Enfermedad
, Femenino
, Humanos
, Hipercolesterolemia/complicaciones
, Hipercolesterolemia/diagnóstico por imagen
, Hipercolesterolemia/tratamiento farmacológico
, Masculino
, Persona de Mediana Edad
, Ultrasonografía Intervencional
Asunto(s)
Hipertensión/terapia , Antihipertensivos/administración & dosificación , Determinación de la Presión Sanguínea/métodos , Ritmo Circadiano , Descompresión Quirúrgica , Quimioterapia Combinada , Humanos , Hipertensión/etiología , Estilo de Vida , Bulbo Raquídeo/irrigación sanguínea , Bulbo Raquídeo/fisiopatología , Flujo Pulsátil , Sistema Nervioso Simpático/fisiopatologíaRESUMEN
It is noted that the increased central sympathetic nerve activity caused by neurovascular compression at the rostral ventrolateral medulla (RVLM) is closely related to the genesis of neurogenic hypertension. The authors present the case of a 49-year-old female with refractory neurogenic hypertension to be uncontrolled even with all kinds of oral antihypertensive medications. After approval by the Ethical Committee in a hospital, she had received an intravenous introduction of calcium antagonist and beta-blocker at home for three years. The subsequent examination detail showed increased sympathetic nerve activity and compression of the left vertebral artery (VA) at the left RVLM on magnetic resonance imaging, and therefore microvascular decompression (MVD) underwent through a left lateral suboccipital approach. The left VA was seen indenting the left RVLM. To ensure the complete decompression, the distal part of VA was moved away from RVLM to fix to the dura of the petrous bone with a glue. Her blood pressure became normalized afterwards without drugs and remained normotensive for 23 months after MVD. In order to decide the surgical indication for pure neurogenic hypertension due to neurovascular compression, a strict differential diagnosis is necessary.
Asunto(s)
Descompresión Quirúrgica , Hipertensión/cirugía , Bulbo Raquídeo , Arteria Vertebral/cirugía , Femenino , Humanos , Hipertensión/etiología , Imagen por Resonancia Magnética , Bulbo Raquídeo/patología , Bulbo Raquídeo/fisiopatología , Persona de Mediana Edad , Síndromes de Compresión Nerviosa/complicaciones , Sistema Nervioso Simpático/patología , Sistema Nervioso Simpático/fisiopatologíaRESUMEN
BACKGROUND: Marked parathyroid hyperplasia with bone diseases and vascular calcification are unsolved issues in dialysis patients. In this study, we made azotemic model rats by adenine feeding and analyzed the development and progression of the abnormalities. METHODS: Renal failure was induced in 8-week-old male Wistar rats by feeding 0.75% adenine-containing diet for 6 weeks. Serum parameters, parathyroid hyperplasia, bone changes and metastatic calcification were examined at 2, 4 and 6 weeks. RESULTS: Progressive increase of serum creatinine and inorganic phosphate, and decreased levels of serum calcium and 1,25(OH)2D3 were confirmed. Markedly enlarged parathyroid glands and extremely high PTH levels were observed in all adenine-fed rats compared with the control (PTH: 199.3+/-58.0 vs 10.5+/-3.0 pmol/l, P<0.01, respectively, at 6 weeks). In cortical bone of the femur, the morphometric parameters showed increased bone resorption with increased fibrosis, whereas in the trabecular bone, bone resorption decreased and bone volume increased with a larger amount of osteoid compared with the control. Metastatic calcification in aorta, coronary artery and other soft tissues were also found in adenine-fed rats. CONCLUSIONS: Uraemic rats made by adenine diet developed severe abnormalities of calcium metabolism in a relatively short period and therefore they may serve as a useful model for the analysis of parathyroid hyperplasia and vascular calcification in chronic renal failure.
Asunto(s)
Enfermedades de la Aorta/etiología , Calcinosis/etiología , Trastorno Mineral y Óseo Asociado a la Enfermedad Renal Crónica/etiología , Enfermedad Coronaria/etiología , Hiperparatiroidismo/etiología , Uremia/complicaciones , Adenina/toxicidad , Animales , Enfermedades de la Aorta/metabolismo , Enfermedades de la Aorta/patología , Nitrógeno de la Urea Sanguínea , Calcinosis/sangre , Calcinosis/patología , Calcitriol/sangre , Calcio/sangre , Trastorno Mineral y Óseo Asociado a la Enfermedad Renal Crónica/metabolismo , Trastorno Mineral y Óseo Asociado a la Enfermedad Renal Crónica/patología , Enfermedad Coronaria/sangre , Enfermedad Coronaria/patología , Creatinina/sangre , Modelos Animales de Enfermedad , Ensayo de Inmunoadsorción Enzimática , Fémur/patología , Estudios de Seguimiento , Hiperparatiroidismo/sangre , Hiperparatiroidismo/patología , Masculino , Microrradiografía , Hormona Paratiroidea/sangre , Ratas , Ratas Wistar , Índice de Severidad de la Enfermedad , Uremia/inducido químicamente , Uremia/patologíaRESUMEN
Although exercise is recommended for the primary prevention of hypertension, and although it is generally known to have a beneficial effect on endothelial function, working individuals often find it difficult to maintain a consistent exercise regimen. In the present study, therefore, we examined the effects of infrequently performed exercise on flow-mediated dilatation (FMD), which is an index of endothelial function, in 15 subjects with hypertension (mild hypertensives) and 10 normotensive subjects (normotensives). All subjects performed mild bicycle exercise twice a week for 12 weeks. To assess the FMD, the diameter of the brachial artery was measured using ultrasound at baseline, during reactive hyperemia, and following sublingual administration of nitroglycerin. Measurement of these parameters was performed twice, at the beginning and the end of the exercise program. At the baseline, FMD was significantly lower in the mild hypertensives than in the normotensives. Nitroglycerin-mediated dilatation (NTG-D) was similar in the two groups. The exercise decreased blood pressure in the mild hypertensives, and increased high-density lipoprotein (HDL) cholesterol in both groups. The exercise improved FMD without altering NTG-D in the mild hypertensives, but did not result in any change in the normotensives. Multiple regression analysis revealed that the elevation in FMD was positively associated with changes in HDL cholesterol, and negatively associated with changes in plasma norepinephrine and systolic blood pressure. These findings suggest that regular exercise at a low frequency improves FMD, and thereby endothelial function, and lowers blood pressure in mild hypertensives.
Asunto(s)
Ejercicio Físico , Hipertensión/fisiopatología , Hipertensión/terapia , Vasodilatación/fisiología , Adulto , Arteria Braquial/fisiología , Endotelio Vascular/fisiología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Óxido Nítrico/metabolismo , Flujo Sanguíneo Regional/fisiología , Análisis de Regresión , Índice de Severidad de la EnfermedadRESUMEN
We examined the relationship between structural changes of the aorta and pulse wave velocity (PWV), and the effects of antihypertensive treatments on PWV in N(omega)-nitro-L-arginine methyl ester (L-NAME)-treated rats. Twelve-week-old Wistar-Kyoto (WKY) rats were divided into the following groups, all of which received drug treatment in their drinking water: an untreated control group (n = 36), an L-NAME-treated group (0.7 mg/ml) (n = 32), an L-NAME and angiotensin converting enzyme (ACE) inhibitor (ACEI)-treated group (imidapril: 0.4 mg/ml) (n = 8), and an L-NAME and hydralazine-treated group (0.2 mg/ml) (n = 10). PWV was measured at the same blood pressure (BP) level as in the control group and the wall-to-lumen ratio of the thoracic aorta was evaluated in all groups. In the L-NAME group, PWV increased compared with the value in the control group, at the same time that BP was increasing. After the third day of treatment, PWV was higher in the L-NAME group than in the control group after adjusting BP to the control level, while the wall-to-lumen ratios were equal between the two groups. After the first week of treatment, not only the adjusted PWV, but also the wall-to-lumen ratios were greater in the L-NAME group than in the control group. With administration of antihypertensive agents, both PWV and the thickening of the aortic wall were reduced, but there was no significant difference between the ACEI and hydralazine-treated groups. In conclusion, in a rat model of nitric oxide (NO) synthesis inhibition, the increase in PWV preceded the vascular structural changes, while antihypertensive treatment reduced both changes. There was no significant difference between treatments with ACEI and hydralazine in this model.
Asunto(s)
Aorta Torácica/fisiología , Arteriosclerosis/fisiopatología , Velocidad del Flujo Sanguíneo/fisiología , Inhibidores Enzimáticos/farmacología , NG-Nitroarginina Metil Éster/farmacología , Flujo Pulsátil/fisiología , Animales , Aorta Torácica/efectos de los fármacos , Aorta Torácica/patología , Arteriosclerosis/inducido químicamente , Arteriosclerosis/patología , Modelos Animales de Enfermedad , Diagnóstico Precoz , Masculino , Óxido Nítrico Sintasa/antagonistas & inhibidores , Ratas , Ratas Endogámicas WKYRESUMEN
A 45-year-old man who had been undergoing maintenance hemodialysis for end-stage renal failure, caused by chronic glomerulonephritis 4 years before, was admitted to our hospital for biventricular pacemaker implantation (BVP). Ten years ago, he was diagnosed with idiopathic dilated cardiomyopathy, and had been suffering from dialysis-related hypotension (DRH) due to low cardiac function over the past year. An electrocardiogram revealed complete left bundle branch block with a QRS duration of 180 ms, and echocardiography showed moderate hypokinesis of the left ventricular wall and systolic asynchronized motion of the septum and free wall. After BVP, the left ventricular ejection fraction had increased from 29% to 40%, and the transmitral rapid left ventricular filling (E wave) and atrial contraction (A wave) ratio (E/A) had improved from 1.3 to 1.0. Before and after BVP, we measured hemodynamic parameters during hemodialysis by successive echocardiography. Before BVP, systemic vascular resistance had decreased, cardiac output had not changed, and hypotension was noted. In contrast, after BVP, cardiac output had increased and systemic vascular resistance had not changed, which caused an increase in blood pressure. We conclude that BVP improved the cardiac function which resulted in an improvement in dialysis-related hypotension (DRH).
Asunto(s)
Estimulación Cardíaca Artificial , Cardiomiopatía Dilatada/complicaciones , Hipotensión/etiología , Hipotensión/terapia , Fallo Renal Crónico/terapia , Diálisis Renal/efectos adversos , Determinación de la Presión Sanguínea , Frecuencia Cardíaca , Humanos , Masculino , Persona de Mediana Edad , Resultado del TratamientoAsunto(s)
Aneurisma de la Aorta Abdominal/etiología , Nefritis Intersticial/etiología , Sarcoidosis/complicaciones , Aneurisma de la Aorta Abdominal/patología , Aneurisma de la Aorta Abdominal/cirugía , Humanos , Masculino , Persona de Mediana Edad , Nefritis Intersticial/patología , Nefritis Intersticial/cirugía , Sarcoidosis/patología , Sarcoidosis/cirugíaRESUMEN
OBJECTIVE: Klotho is thought to play a critical role in the development of age-related disorders including arteriosclerosis. Statins may exert vascular protective effects, independent of the lowering of plasma cholesterol levels. We investigated the impact of statins on mRNA expression of the age-suppressor gene, klotho in mIMCD3 cells. METHODS AND RESULTS: Klotho mRNA levels were evaluated with real-time RT-PCR. Atorvastatin and pitavastatin increased the expression of klotho mRNA in a dose-dependent manner. This stimulatory effect was abolished by the addition of mevalonate, GGPP and FPP, essential molecules for isoprenylation of the small GTPase Rho. As was the case with the statin treatment, inhibition of Rho-kinase by Y27632 up-regulated klotho mRNA. In contrast to the statin treatment, stimulation with angiotensin II down-regulated klotho mRNA expression without obvious morphological changes. Furthermore, pretreatment with atorvastatin blunted the angiotensin II-induced response and ameliorated the decrease in klotho mRNA expression towards basal levels. RhoA activity was further evaluated by detection of its translocation. Angiotensin II activated RhoA, whereas statins potently inactivated RhoA and blocked RhoA activation by angiotensin II. CONCLUSION: Statins inactivate the RhoA pathway, resulting in over-expression of klotho mRNA, which may contribute to the novel pleiotropic effects of statins towards vascular protection.